Nader Z. Pourhassan
2021
In 2021, Nader Z. Pourhassan earned a total compensation of $10M as President and Chief Executive Officer at CytoDyn, a 1% increase compared to previous year.
Compensation breakdown
| Bonus | $800,000 |
|---|---|
| Non-Equity Incentive Plan | $200,000 |
| Option Awards | $4,238,000 |
| Salary | $1,000,000 |
| Stock Awards | $3,750,090 |
| Other | $57,417 |
| Total | $10,045,507 |
Pourhassan received $4.2M in option awards, accounting for 42% of the total pay in 2021.
Pourhassan also received $800K in bonus, $200K in non-equity incentive plan, $1M in salary, $3.8M in stock awards and $57.4K in other compensation.
Rankings
In 2021, Nader Z. Pourhassan's compensation ranked 1,033rd out of 12,405 executives tracked by ExecPay. In other words, Pourhassan earned more than 91.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,033 out of 12,405 | 92nd |
Division Manufacturing | 347 out of 5,494 | 94th |
Major group Chemicals And Allied Products | 119 out of 2,369 | 95th |
Industry group Drugs | 101 out of 2,090 | 95th |
Industry Pharmaceutical Preparations | 68 out of 1,537 | 96th |
Source: SEC filing on October 26, 2022.
Pourhassan's colleagues
We found two more compensation records of executives who worked with Nader Z. Pourhassan at CytoDyn in 2021.